Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 40 | 2024 | 8721 | 1.180 |
Why?
|
| Plaque, Amyloid | 9 | 2021 | 769 | 0.710 |
Why?
|
| Autoradiography | 1 | 2019 | 732 | 0.600 |
Why?
|
| tau Proteins | 10 | 2024 | 2129 | 0.590 |
Why?
|
| Isoquinolines | 1 | 2019 | 354 | 0.570 |
Why?
|
| Neurofibrillary Tangles | 9 | 2024 | 458 | 0.560 |
Why?
|
| Leukoaraiosis | 1 | 2018 | 116 | 0.550 |
Why?
|
| Fluorine Radioisotopes | 2 | 2019 | 425 | 0.540 |
Why?
|
| Amyloid beta-Peptides | 16 | 2021 | 3891 | 0.460 |
Why?
|
| Brain | 20 | 2024 | 27438 | 0.440 |
Why?
|
| Apolipoproteins E | 13 | 2019 | 1461 | 0.390 |
Why?
|
| Carbolines | 3 | 2017 | 296 | 0.340 |
Why?
|
| Neurodegenerative Diseases | 2 | 2019 | 1095 | 0.340 |
Why?
|
| Positron-Emission Tomography | 6 | 2019 | 6657 | 0.320 |
Why?
|
| Apolipoprotein E4 | 8 | 2018 | 712 | 0.280 |
Why?
|
| Cognition Disorders | 3 | 2018 | 3985 | 0.250 |
Why?
|
| Lewy Body Disease | 3 | 2019 | 253 | 0.230 |
Why?
|
| Cytokines | 1 | 2018 | 7449 | 0.220 |
Why?
|
| Gliosis | 1 | 2003 | 246 | 0.200 |
Why?
|
| Entorhinal Cortex | 3 | 2016 | 288 | 0.190 |
Why?
|
| Caregivers | 3 | 2023 | 2302 | 0.190 |
Why?
|
| Parkinson Disease | 4 | 2019 | 2891 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 5 | 2008 | 4417 | 0.170 |
Why?
|
| Temporal Lobe | 4 | 2016 | 1728 | 0.160 |
Why?
|
| Movement Disorders | 1 | 2003 | 464 | 0.160 |
Why?
|
| Peptide Fragments | 4 | 2019 | 5152 | 0.160 |
Why?
|
| Aged, 80 and over | 26 | 2024 | 59680 | 0.150 |
Why?
|
| Neuropsychological Tests | 7 | 2021 | 7134 | 0.150 |
Why?
|
| Least-Squares Analysis | 1 | 2018 | 368 | 0.150 |
Why?
|
| Sex Characteristics | 2 | 2019 | 2666 | 0.150 |
Why?
|
| Neurobehavioral Manifestations | 1 | 1996 | 10 | 0.140 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2019 | 419 | 0.140 |
Why?
|
| Olfactory Perception | 1 | 2016 | 65 | 0.130 |
Why?
|
| Dopamine | 1 | 2003 | 1616 | 0.130 |
Why?
|
| Cerebral Cortex | 5 | 2017 | 5827 | 0.120 |
Why?
|
| Encephalitis | 1 | 2018 | 441 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2018 | 4138 | 0.110 |
Why?
|
| Motor Cortex | 1 | 2021 | 1015 | 0.110 |
Why?
|
| Heterozygote | 1 | 2019 | 2792 | 0.100 |
Why?
|
| Radiopharmaceuticals | 2 | 2019 | 2731 | 0.100 |
Why?
|
| Aged | 34 | 2024 | 171520 | 0.100 |
Why?
|
| Hippocampus | 6 | 2024 | 3783 | 0.090 |
Why?
|
| alpha-Synuclein | 4 | 2007 | 765 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2021 | 1472 | 0.090 |
Why?
|
| Humans | 54 | 2024 | 768451 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2024 | 36840 | 0.090 |
Why?
|
| Neural Pathways | 2 | 2013 | 3122 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 1892 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2010 | 1943 | 0.080 |
Why?
|
| Longitudinal Studies | 7 | 2019 | 14766 | 0.080 |
Why?
|
| Polymorphism, Genetic | 4 | 2010 | 4249 | 0.080 |
Why?
|
| Substantia Nigra | 2 | 2003 | 348 | 0.080 |
Why?
|
| Linear Models | 2 | 2018 | 5880 | 0.080 |
Why?
|
| Male | 27 | 2024 | 364781 | 0.080 |
Why?
|
| Synucleins | 3 | 2003 | 108 | 0.080 |
Why?
|
| Female | 28 | 2024 | 396943 | 0.080 |
Why?
|
| Amyloid | 2 | 2016 | 852 | 0.070 |
Why?
|
| Disease Progression | 5 | 2021 | 13655 | 0.070 |
Why?
|
| Aging | 3 | 2016 | 8761 | 0.070 |
Why?
|
| Aniline Compounds | 3 | 2019 | 1094 | 0.070 |
Why?
|
| Atrophy | 4 | 2017 | 1648 | 0.070 |
Why?
|
| Calpain | 1 | 2007 | 147 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 12096 | 0.060 |
Why?
|
| Axons | 1 | 2013 | 1678 | 0.060 |
Why?
|
| Thiazoles | 3 | 2019 | 1541 | 0.060 |
Why?
|
| Case-Control Studies | 4 | 2018 | 22293 | 0.060 |
Why?
|
| History, 19th Century | 1 | 2008 | 716 | 0.060 |
Why?
|
| Mice, Transgenic | 6 | 2013 | 9558 | 0.060 |
Why?
|
| Genotype | 12 | 2010 | 13047 | 0.060 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2004 | 142 | 0.060 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2003 | 107 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 15965 | 0.050 |
Why?
|
| Middle Aged | 19 | 2023 | 223418 | 0.050 |
Why?
|
| Neurons | 8 | 2007 | 9504 | 0.050 |
Why?
|
| Activities of Daily Living | 2 | 2023 | 2433 | 0.050 |
Why?
|
| Oxidative Phosphorylation | 1 | 2005 | 501 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2007 | 5042 | 0.050 |
Why?
|
| Cell Count | 2 | 1998 | 1835 | 0.050 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2003 | 370 | 0.050 |
Why?
|
| Proxy | 1 | 2022 | 151 | 0.050 |
Why?
|
| Maze Learning | 1 | 2003 | 484 | 0.050 |
Why?
|
| Personal Autonomy | 1 | 2023 | 315 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 20231 | 0.040 |
Why?
|
| Tauopathies | 1 | 2024 | 328 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2008 | 2772 | 0.040 |
Why?
|
| Social Participation | 1 | 2021 | 185 | 0.040 |
Why?
|
| Indans | 1 | 2000 | 92 | 0.040 |
Why?
|
| Neurites | 2 | 1998 | 391 | 0.040 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2000 | 173 | 0.040 |
Why?
|
| Decision Making | 2 | 2023 | 3961 | 0.040 |
Why?
|
| Neuropil | 1 | 1998 | 31 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2004 | 1115 | 0.040 |
Why?
|
| alpha-Macroglobulins | 1 | 1998 | 60 | 0.040 |
Why?
|
| Arabidopsis Proteins | 1 | 2000 | 265 | 0.040 |
Why?
|
| Nootropic Agents | 1 | 2000 | 159 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2024 | 663 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2000 | 376 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2021 | 8332 | 0.040 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 26351 | 0.040 |
Why?
|
| Lewy Bodies | 1 | 1998 | 141 | 0.040 |
Why?
|
| Electromyography | 1 | 2003 | 1399 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2021 | 876 | 0.040 |
Why?
|
| Choice Behavior | 1 | 2023 | 846 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2024 | 9066 | 0.040 |
Why?
|
| Alleles | 6 | 1998 | 6890 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2003 | 1173 | 0.030 |
Why?
|
| Risperidone | 1 | 1999 | 383 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 2751 | 0.030 |
Why?
|
| Endocytosis | 1 | 2000 | 960 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2016 | 315 | 0.030 |
Why?
|
| Patient Preference | 1 | 2023 | 948 | 0.030 |
Why?
|
| Autopsy | 1 | 2019 | 1013 | 0.030 |
Why?
|
| Prealbumin | 2 | 2010 | 259 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 18388 | 0.030 |
Why?
|
| Age of Onset | 3 | 1996 | 3342 | 0.030 |
Why?
|
| Risk | 2 | 2019 | 9642 | 0.030 |
Why?
|
| Drug Approval | 1 | 2021 | 817 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 1448 | 0.030 |
Why?
|
| Cocaine | 1 | 2019 | 960 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2004 | 12813 | 0.030 |
Why?
|
| Animals | 10 | 2013 | 169418 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2000 | 1204 | 0.030 |
Why?
|
| Neuropeptides | 1 | 1998 | 950 | 0.030 |
Why?
|
| Immunohistochemistry | 4 | 2013 | 11138 | 0.030 |
Why?
|
| Gene Frequency | 3 | 2010 | 3615 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2014 | 227 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 551 | 0.020 |
Why?
|
| Molecular Sequence Data | 4 | 2000 | 17647 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2000 | 914 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1997 | 1415 | 0.020 |
Why?
|
| Mice | 7 | 2013 | 82045 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 16029 | 0.020 |
Why?
|
| Piperidines | 1 | 2000 | 1664 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2007 | 22365 | 0.020 |
Why?
|
| Base Sequence | 3 | 1996 | 12428 | 0.020 |
Why?
|
| Adult | 5 | 2019 | 223542 | 0.020 |
Why?
|
| Gelsolin | 1 | 2010 | 189 | 0.020 |
Why?
|
| Gene Expression | 1 | 2003 | 7605 | 0.020 |
Why?
|
| Spain | 1 | 2010 | 491 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2000 | 3145 | 0.020 |
Why?
|
| Amyloidosis | 1 | 2016 | 879 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2016 | 1422 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1997 | 1553 | 0.020 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 1995 | 897 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 1998 | 1668 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2010 | 792 | 0.020 |
Why?
|
| Genes | 1 | 2010 | 1824 | 0.020 |
Why?
|
| Contrast Media | 1 | 2019 | 5336 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 1999 | 3077 | 0.020 |
Why?
|
| Annelida | 1 | 2005 | 7 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2863 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 1727 | 0.020 |
Why?
|
| Shaw Potassium Channels | 1 | 2004 | 20 | 0.020 |
Why?
|
| Diptera | 1 | 2005 | 50 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 876 | 0.010 |
Why?
|
| Massachusetts | 2 | 2014 | 8908 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 1223 | 0.010 |
Why?
|
| Mutation | 3 | 2004 | 30243 | 0.010 |
Why?
|
| Age Factors | 2 | 1999 | 18478 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1995 | 2665 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 440 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2007 | 1640 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2005 | 414 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 2477 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 4120 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2005 | 596 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 682 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 2008 | 1487 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2004 | 943 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2016 | 6740 | 0.010 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2000 | 47 | 0.010 |
Why?
|
| Presenilin-2 | 1 | 2000 | 100 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2000 | 317 | 0.010 |
Why?
|
| Risk Factors | 4 | 2010 | 74915 | 0.010 |
Why?
|
| Prevalence | 1 | 1997 | 15880 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2008 | 54914 | 0.010 |
Why?
|
| Choroid Plexus | 1 | 2002 | 248 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2005 | 1078 | 0.010 |
Why?
|
| Drosophila | 1 | 2007 | 1514 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 2423 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 12561 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2002 | 962 | 0.010 |
Why?
|
| Isoleucine | 1 | 1998 | 112 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1999 | 6879 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2002 | 1891 | 0.010 |
Why?
|
| Basal Ganglia Diseases | 1 | 1999 | 145 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2000 | 732 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2004 | 1427 | 0.010 |
Why?
|
| Synaptophysin | 1 | 1998 | 140 | 0.010 |
Why?
|
| Pyramidal Cells | 1 | 2000 | 367 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4586 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 426 | 0.010 |
Why?
|
| Endosomes | 1 | 2000 | 526 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 18048 | 0.010 |
Why?
|
| Iowa | 1 | 1996 | 104 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1998 | 699 | 0.010 |
Why?
|
| Valine | 1 | 1998 | 410 | 0.010 |
Why?
|
| Prognosis | 2 | 2014 | 30028 | 0.010 |
Why?
|
| Gene Expression Profiling | 2 | 2004 | 9507 | 0.010 |
Why?
|
| Ubiquitins | 1 | 1998 | 367 | 0.010 |
Why?
|
| Presenilin-1 | 1 | 2000 | 669 | 0.010 |
Why?
|
| Cell Size | 1 | 1998 | 626 | 0.010 |
Why?
|
| Dendrites | 1 | 1998 | 471 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 2002 | 1034 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 1998 | 337 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2000 | 1972 | 0.010 |
Why?
|
| Rats | 2 | 2002 | 23839 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1998 | 1706 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2000 | 1129 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2000 | 2103 | 0.010 |
Why?
|
| Cognition | 2 | 2002 | 7066 | 0.010 |
Why?
|
| Cell Death | 1 | 1998 | 1684 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2000 | 2944 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 6135 | 0.010 |
Why?
|
| Fetus | 1 | 2000 | 1883 | 0.010 |
Why?
|
| Molecular Biology | 1 | 1996 | 573 | 0.010 |
Why?
|
| Dementia | 2 | 1998 | 2723 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 1998 | 1977 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2017 | 81834 | 0.010 |
Why?
|
| Gestational Age | 1 | 2000 | 3615 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4362 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 17149 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 4941 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 1996 | 1820 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1996 | 4622 | 0.000 |
Why?
|
| Follow-Up Studies | 2 | 2000 | 39430 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 6091 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1999 | 10784 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1998 | 9687 | 0.000 |
Why?
|
| Cohort Studies | 2 | 2000 | 41797 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 2000 | 12450 | 0.000 |
Why?
|
| Glioma | 1 | 2000 | 3523 | 0.000 |
Why?
|
| DNA | 1 | 1998 | 7213 | 0.000 |
Why?
|
| Apoptosis | 1 | 2000 | 9526 | 0.000 |
Why?
|
| Logistic Models | 1 | 1998 | 13324 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 15460 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 2000 | 7895 | 0.000 |
Why?
|
| Treatment Outcome | 2 | 2000 | 65409 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1998 | 9263 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2000 | 26395 | 0.000 |
Why?
|
| Infant | 1 | 2000 | 36497 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2000 | 42623 | 0.000 |
Why?
|
| Child | 1 | 2000 | 80863 | 0.000 |
Why?
|
| Adolescent | 1 | 2000 | 89168 | 0.000 |
Why?
|
Concepts
(244)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(63)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_